Successful compound management and biological sample management stand as key enablers within the drug discovery process.
This report highlights the key focus areas in both Compound Management and Biological Sample Management to provide you with an insight into the key challenges, growth areas investment trends.
Market members have noted that traditionally researchers approach a biobank with a focus on purely their access a sample of a certain nature. However, a large flaw lies in the fact that they can often fail to query the quality of said samples at the point of sourcing. Instead, questions about quality are left to be asked in the late stages and within extreme situations.
This report focuses n the strategies that can help organisations improve sample usability and operate more efficiently.
Ahead of the Global Biobanking Forum Pharma IQ spoke to key speakers Heli Salimen-Mankonen, Research Director, Auria Biobank and Francisco de Luna, Deputy Coordinator of the National Biobank Network, CNIO about enhancing sustainability and the steps they are taking to create a successful sustainable biobank.